本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

150.02
-7.2000-4.58%
盤後150.020.00000.00%19:54 EDT
成交量:133.22萬
成交額:2.01億
市值:153.02億
市盈率:21.99
高:156.70
開:156.70
低:149.15
收:157.22
52周最高:186.12
52周最低:122.14
股本:1.02億
流通股本:9,999.56萬
量比:1.50
換手率:1.33%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率:22.09%
總資產收益率:11.70%
市淨率:4.14
市盈率(LYR):32.12

資料載入中...

2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

重要事件披露

Form 8-K - Current report